Allegheny Financial Group LTD Clovis Oncology, Inc. Transaction History

Allegheny Financial Group LTD

  • $397 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022
SELL
$1.05 - $2.85 $497 - $1,350
-474 Reduced 3.29%
13,950 $16,000
Q1 2022

May 11, 2022
SELL
$1.43 - $3.14 $965 - $2,119
-675 Reduced 4.47%
14,424 $29,000
Q4 2021

Feb 09, 2022
SELL
$2.7 - $4.76 $2,025 - $3,570
-750 Reduced 4.73%
15,099 $40,000
Q4 2020

Feb 11, 2021
BUY
$4.13 - $6.41 $65,456 - $101,592
15,849 New
15,849 $76,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Allegheny Financial Group LTD Portfolio

Follow Allegheny Financial Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allegheny Financial Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Allegheny Financial Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email